Inhibition of glutathione conjugation in the rat in vivo by analogues of glutathione conjugates

Chemico-Biological Interactions

Volumn 111-112, Issue , 1998, Pages 163-176

  Ouwerkerk Mahadevan, Sivi ^a   Mulder, Gerard J ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Bromsulfthalein; Glutathione conjugation; Glutathione transferase; Inhibitors; Stereoselectivity

Indexed keywords

AMINOADIPIC ACID; BROMSULFOPHTHALEIN; GLUTATHIONE; GLUTATHIONE DERIVATIVE; GLUTATHIONE TRANSFERASE;

ANIMAL CELL; ARTICLE; ENZYME INHIBITION; GLUTATHIONE METABOLISM; LIPID SOLUBILITY; LIVER CELL; NONHUMAN; PROTEIN BINDING; RAT; STRUCTURE ACTIVITY RELATION;

ANIMALS; BINDING SITES; CYTOSOL; DRUG STABILITY; ENZYME INHIBITORS; GLUTATHIONE; GLUTATHIONE TRANSFERASE; HUMANS; ISOENZYMES; LIPID METABOLISM; LIVER; PERFUSION; PROTEIN BINDING; RATS; SOLUBILITY; STRUCTURE-ACTIVITY RELATIONSHIP; SULFOBROMOPHTHALEIN;

EID: 0032562529     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-2797(97)00159-2     Document Type: Article

References (20)

1. Mannervik B., Danielson U.H. Glutathione transferases - structure and catalytic activity. CRC Rev. Biochem. 23:1988;283-337.
2. Ketterer B., Mulder G.J. Glutathione conjugation. Mulder G.J. Conjugation Reactions in Drug Metabolism. 1990;307-364 Taylor and Francis, London.
3. Commandeur J.N.M., Stijntjes G.J., Vermeulen N.P.E. Enzymes and transport systems involved in the formation and disposition of glutathione S-conjugates. Pharmacol. Rev. 47:1995;271-330.
4. Hayes J.D., Pulford D.J. The glutathione S-transferase supergene family: Regulation of GST and the contribution of the isoenzymes to cancer chemoprevention and drug resistance. Crit. Rev. Biochem. Mol. Biol. 30:1995;445-600.
5. Mulder G.J., Ouwerkerk-Mahadevan S. Modulation of glutathione conjugation in vivo: How to decrease glutathione conjugation in vivo or in intact cellular systems in vitro. Chem. Biol. Interact. 105:1997;17-34.
6. O'Dwyer P.J., LaCreta F., Nash S., Tinsley P.W., Schilder R., Clapper M.L., Tew K.D., Panting L., Litwin S., Comis R.L., Ozols R.F. Phase I study of thiotepa in combination with the glutathione transferase inhibitor ethacrynic acid. Cancer Res. 51:1991;6059-6065.
7. Ouwerkerk-Mahadevan S., van Boom J.H., Dreef-Tromp M.C., Ploemen J.H.T.M., Meyer D.J., Mulder G.J. Glutathione analogues as novel inhibitors of rat and human glutathione S-transferase isoenzymes, as well as of glutathione conjugation in isolated rat hepatocytes and the rat in vivo. Biochem. J. 308:1995;283-290.
8. Ouwerkerk-Mahadevan S., van Boom J.H., Mulder G.J. Isoenzyme-selective inhibition of glutathione conjugation in vivo: Selective inhibition of the conjugation of S-2-bromoisovalerylurea in the rat. J. Pharmacol. Exp. Ther. 276:1996;923-928.
9. Adang A.E.P., Brussee J., Meyer D.J., Coles B., Ketterer B., van der Gen A., Mulder G.J. Substrate specificity of rat liver glutathione S-transferase isoenzymes for a series of glutathione analogues modified at the γ-glutamyl moiety. Biochem. J. 255:1988;721-724.
10. Adang A.E.P., Brussee J., van der Gen A., Mulder G.J. The glutathione binding site in glutathione S-transferases: Investigations of the cysteinyl, glycyl and γ-glutamyl domains. Biochem. J. 269:1990;47-54.
11. S. Ouwerkerk-Mahadevan, Inhibition of glutathione conjugation in vitro and in the rat in vivo, Ph.D. Thesis, Leiden University, 1997.
12. Pang K.S., Gillette J.R. Kinetics of metabolite formation and elimination in the perfused rat liver preparation: Differences between elimination of the preformed acetaminophen formed from phenacetin. J. Pharmacol. Exp. Ther. 207:1978;178-194.
13. van der Aar E.M., Bouwman T., Commandeur J.N.M., Vermeulen N.P.E. Structure-activity relationships for chemical and glutathione S-transferase catalyzed glutathione conjugation reactions of a series of 2-substituted 1-chloro-4-nitrobenzenes. Biochem. J. 320:1996;531-540.
14. te Koppele J.M., Dogterom P., Vermeulen N.P.E., Meijer D.K.F., van der Gen A., Mulder G.J. 2-Bromoisovalerylurea as model substrate for studies on pharmacokinetics of glutathione conjugation in the rat II. Pharmacokinetics and stereoselectivity of metabolism and excretion in vivo and in the perfused rat liver. J. Pharmacol. Exp. Ther. 239:1986;905-914.
15. Polhuijs M., Meijer D.K.F., Mulder G.J. The fate of diatereomeric glutathione conjugates of 2-bromoiosvalerylurea in blood in the rat in vivo and in the liver perfusion. J. Pharmacol. Exp. Ther. 256:1991;458-461.
16. Mulders T.M.T., Venizelos V., Schoemakers R., Cohen A.F., Breimer D.D., Mulder G.J. Characterization of glutathione conjugation in man: Stereoselectivity in plasma elimination kinetics and urinary excretion of (R)- and (S)-2-bromoisovalerylurea in healthy volunteers. Clin. Pharmacol. Ther. 58:1993;49-58.
17. te Koppele J.M., Coles B., Ketterer B., Mulder G.J. Stereoselectivity of rat liver glutathione transferase isoenzymes for 2-bromoisovaleryluric acid and 2-bromoisovalerylurea enantiomers. Biochem. J. 252:1988;137-142.
18. Armstrong R.N. Structure, catalytic mechanism and evolution of the glutathione transferases. Chem. Res. Toxicol. 10:1997;2-18.
19. Lyttle M.H., Hocker M.D., Hui H.C., Caldwell C.G., Aaron D.T., Enquist-Goldstein A., Flatgaard J.E., Bauer K.E. Isoenzyme-specific glutathione S-transferase inhibitors: Design and synthesis. J. Med. Chem. 37:1994;189-194.
20. Morgan A.S., Ciaccio P.J., Tew K.D., Kauvar L.M. Isoenzyme specific glutathione S-transferase inhibitors potentiate drug sensitivity in cultured human tumor cell lines. Can. Chemother. Pharmacol. 37:1996;363-370.